A New Approach to Imaging Focal Liver Lesions in Patients With Reduced Kidney Function. In the February 2022 edition of the journal International Clinical Trials, you can read about our novel contrast agent Orviglance.
Download the full article below (This article is taken from International Clinical Trials February 2022, pages 38-40 © Samedan Ltd).
